TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.

Featured Posts

Webinar Invitation: Integrating Drones into Immunization Supply Chains

Hello TechNet-21 members, 

The UAV for Payload Delivery Working Group (UPDWG) invite you to attend a special, one and a half hour webinar, jointly hosted by UPDWG and TechNet-21 on integrating drones into immunization supply chains.  Webinar: Integrating Drones into Immunization Supply Chains When: November 7, 2019 | 10-11:30 AM EST Description: Resilient, high-performing immunization supply chains (iSCs) are the basis for strong primary health care systems and the foundation for reaching global immunization coverage and equity targets. Yet efficient and reliable transportation for immunization products still remains a challenge in many low and middle-income countries. New technologies, such as drones, have the potential to revolutionize traditional modes of transportation but how do you know if these technologies are the right fit for your context?
In this webinar, UPDWG and TechNet-21 will explore when integrating drones (or UAVs) into existing iSCs is feasible and how you can operationalize drones in existing immunization programs. UPDWG Members from UNICEF and VillageReach will share their experiences from Vanuatu and the Democratic Republic of Congo (DRC), in integrating drones transportation into the routine immunization supply chain.  After the presentations, we will open the floor for a panel discussion with VillageReach DRC and former UNICEF Vanuatu staff.  Hosts: 
Olivier Defawe - UPDWG
Daniel Brigden - TechNet-21, The Technical Network for Strengthening Immunization Services

Case Study Presenters: 
Jaime Archundia - UAS Global Lead, UNICEF
Luciana Maxim - Sr. Manager, Research Evidence and Learning, VillageReach

Discussion Panelists: 
Ridwan Gustiana - Health Specialist, Immunization UNICEF (formerly UNICEF Vanuatu) 
Archimede Makaya - Equateur Provincial Coordinator, VillageReach DRC
Dieudonne Nsekela - Program Officer, New Technologies, VillageReach DRC
Christian Vazquez - Civil Engineer, Transportation Engineering (formerly UNICEF Vanuatu)  Registration: https://zoom.us/meeting/register/c638a89ac5516f0d8c34be5db4a05ad8   I hope you can join us for this exciting webinar!    Best,  Gabriella Ailstock Coordinator, UAV for Payload Delivery Working Group (UPDWG) info@UPDWG.org | UPDWG.org

Discussion: The IDEAL-Vietnam project would like global feedback and collaboration on the topic of, “Partnering with Mobile Network Operators for electronic immunization registry application”, after the release of the project’s first case study.

The PATH, Introducing Digital immunization information systems- Exchange and Learning (IDEAL) project, funded by the Bill & Melinda Gates Foundation is excited to release the first lessons learned on transitioning from a paper-based immunization registry to an entirely digital system. The case study reflects necessary partnerships in the development and scale-up of current electronic immunization registry (EIR) in Vietnam, the National Immunization Information System (NIIS). The study describes the benefits and challenges of partnerships between the Ministry of Health, PATH and Mobile Network Operator (Viettel). Both local governments, partnering NGOs and Mobile Network Operators play a vital role in the application of a software-based immunization registry, but as Vietnam’s story demonstrates there is both critical advanced planning and necessary steps to ensure these partnerships are as strong and sustainable as possible, maximizing both resources and time to increase health benefits. The study discusses the development of partnerships that enabled the successful scale-up of Vietnam’s NIIS from a pilot project to a nation-wide application. The World Health Organizations, “A practical guide for engaging with mobile network operators in Health for reproductive, maternal, newborn and child health” was used as a comparative guide in the case study, to relate Vietnam’s experience to existing EIR global resources. The case study highlights the benefits of key partnerships in EIR implementation and drivers for cultivating partnerships from both MNO and MOH perspectives. The report also demonstrates the hurdles that Vietnam experienced, demonstrating when possible, how Vietnam was able to overcome the challenges as the country continues to transition to an entirely digital immunization registry. The first lesson learned case study also serves as a gateway to introduce IDEAL’s new homepage on TechNet-21, where you can find all IDEAL- project reports, announcements and materials in English and Vietnamese. Over the course of the next two years IDEAL-project will explore more lessons learned from Vietnam in the process of moving to completely digital, each zoning-in on an important aspect of the electronic immunization registry process.   IDEAL-Vietnam project would like your feedback on the first case study and first topic of our lessons learned library, “Partnering with Mobile Network Operators”: 1.) What has been some of your countries/organization’s key challenges in the identification, formation, or maintenance of a partnership with a MNO?   2.) What lessons learned or take-away message did you find most valuable for our case study?   3.) What are some lessons learned or take-away messages you think are important to share from your country/organizations experience/partnerships?   4.) What are some other global guidance documents your country/organization have used to determine best practice for forming necessary partnerships for the EIR application?   5.) What aspects from the Vietnam perspective can your own country/organization relate to in regard to the partnerships formed for EIR application? What aspects are less relatable?   6.) If the IDEAL-project could expand/revise this case study in the future what areas would be most helpful to detail further?  

New Topic Page: Dose Per Container (DPC)

The recently published topic page on dose per container (DPC) provides a range of useful resources from case studies to decision support documents to better understand the effects of DPC on six immunization system components; namely operational costs, timely coverage, safety, wastage, and policy/correct use.   The Dose Per Container Partnership (DPCP) is excited to share these resources and hope that you will find them useful in your work with the immunization system as a whole. We encourage you to share your thoughts with us to continue the conversation on DPC.

An Alternative to Energy Harvesting Controls (EHC)

EHC is a valuable method of obtaining excess energy from an SDD refrigerator, however an autonomous solar direct system powering USB ports is a simpler, more reliable and less expensive method of providing auxiliary power. USB ports can be powered directly from a solar panel, no batteries are required. The conversion device is simple and reliable; these ports can be used for charging cell phones, ipads, lights and AA or AAA batteries.There are a large variety of lights available: lanterns, directional lights, headlamps and lights with motion sensors. Jump starting car batteries can also be charged by a USB port. If desired a 12 volt port could also be incorporated to power a fan and if needed a 12 Volt battery. USB charged devices typically require an average of 3 watts of charging power. Twelve watts of solar per USB port will supply reliable charging at the beginning and end of the solar day and during overcast conditions. For 4 ports a 48 watt module would provide highly reliable power. This would charge at least 8 devices each day. Having an autonomous system for auxiliary loads has a number of advantages: - With EHC’s the controller is designed for a specific brand and model of refrigerator. An autonomous solar system will work with all types of refrigerators.
- As a consequence of working with only a specific brand and model of refrigerators the aggregate cost of testing will be very high.
- Testing must also be carried out for each specific type of load, resistive, battery charging, etc.
- Trouble shooting system in the field will be much simpler with an autonomous power system there will not be the possibility of interaction between the two systems.
- The autonomous system with USB ports would be inexpensive and easy to install.
- When solar conditions are poor the autonomous system will provide more reliable power for a greater portion of the day. I would be glad to discuss the pros and cons of this system further. EHC’s are a good concept because a 60 watt load is typically powered by a 300 watt array. However, I think a separate autonomous system is a more appropriate solution.

Remerciements

Merci pour les documents.Y'a t-il des versions en français ? 

Learning is a continuous process - an example

Dear viewers   Learning is a continuous prosess, attached is one such example applicable for the entire country with ~28000 planning units; presenting the attachment as an evidence for continuous learning.   With best wishes  Holla n Team  

New Missed Opportunities for Vaccination topic page on TechNet

We are pleased to announce the launch of the topic page for Missed Opportunities for Vaccination (MOV) on TechNet: https://www.technet-21.org/en/topics/mov The MOV topics page includes tables with information about: • MOV publications
• MOV training material
• Interventions to reduce MOV by addressing health worker knowledge, attitudes and practice
• Interventions to reduce MOV by addressing health systems issues
• Interventions to reduce MOV by addressing the demand-side (caregiver behaviours) The launch of this page also coincides with the finalization of the Intervention guidebook for implementing and monitoring activities to reduce Missed Opportunities for Vaccination (MOV). The purpose of the Intervention Guidebook is to provide practical advice on how to ensure a smooth transition between Steps 6 and 7, and guidance to countries in implementing the final steps (Steps 7–10) of the 10-step MOV strategy. These steps will help putting the assessment findings into practice. The guide also includes frequent reasons for MOV, an overview of potential interventions to reduce MOV, examples of job aids and other materials for use at the health facility level, and guidance for activities and processes to explore and design locally tailored interventions to reduce MOV. As new publications, training material and interventions to reduce MOV become available, we will update them to the relevant table. If there are any interventions not included in the guide or in the tables, let us know! I hope you enjoy the MOV topics page and if you like further information related to MOV it can be found here: https://www.who.int/immunization/programmes_systems/policies_strategies/MOV/en/ A big thank you to Dan Brigden, Alex Pascutto and Alex Lee for their support in developing this page!

immunization schedule for children who have missed the routine immunization

What are the vaccines that could be given to children who have missed their immunization as scheduled? Some children come at 1 year, 2 years and even at 3 years of age without receiving any vaccine or only a few of them. I would like to know what vaccines could be given at various ages for children who have missed required injections of vaccines. Dr. Dhrupthob sonam

Enlightening the CUSTODIANS of Mantoux Test [Tuberculin Skin Test – TST]

Dear viewers  we feel proud to share the following. Though the decision making is with the professionals, many skilled procedures like parenteral administration of medicines through ID / SC / IM / IV, insertion of nasogastric tube, IV canula proper use of AMBU (artificial manual breathing unit) bags with or without oxygen for resuscitating asphyxiated newborn, preparing slides, proper staining and reading slides under microscope to look for Malaria parasites, mycobacteria etc. are with the nursing staff / lab technicians. Hence, adequate training, retraining, periodic supportive supervision on a regular basis, supporting peer education for rapid expansion & sustenance of capacity building certainly strengthens implementation of national health programmes. Legacy from the polio eradication programme, president success stories are very much useful in timely elimination of Tuberculosis. Coming to the point: As shared on 01st June, proper administration of tuberculin as per the “Rights” in all thematic areas by the staff nurses / lab technicians [TST testers] decides the outcome of the test: induration or no induration which influences the decision of treating doctor and the fate of the patients who adore doctor’s decision; the foundation of programme success. On observing and sharing innumerable lapses in administering TST in the last two years, author was asked to conduct a CME to the “TST testers” of medical colleges of Dakshina Kannada district which was held on 01 June and to share the experiences as feedback in the State Task Force (STF) meeting held on 07 June for way forward. We wish to share the feedback presented on 7th June with the viewers of techNet-21. Way forward: The ZTF chair / STF chair / JD and DD tuberculosis of Karnataka state on the spot expressed that one day training has to be conducted for the “TST testers” of all Medical Colleges in batches of 18-21 at the Demosite established in KVG Medical College, functioning since April 2016. We trained 144 Staff Nurses of Mobile Medical Units (MMU’s) of 27 districts of Karnataka in Extended Immunogram between 11-03-2017 & 10-06-2017. Management of KVG Medical College gracefully provided free accommodation to the participants. We are now ready to train the TST “Testers” of all Medical Colleges of Karnataka. Acknowledgement: India is committed, Karnataka is more committed. KVG team is heartily indebted to the ZTF / STF chairs, JD / DD-TB Karnataka, WHO consultants, all the RNTCP nodal officers of all the Medical Colleges of Karnataka & DTO Dakshina Kannada. Attached is the feedback presented in the STF meeting at Bangalore on 7th June 2019. with best wishes Holla n Team    

Given mOPV2 and bOPV to eligible child during campaign

Dear all I encountered operational challege were during SIA, specifically OBR using mOPV2 antigen. I observed that the fixed post team were given only bOPV which is the right antigen for routine while ignoring the purpose of the campaign (mOPV2 not given). They were intructed to give both mOPV2 and bOPV concurrently in other to ensure children received RI and SIA doses. When we reffered to the stakeholders it was revealed that guideline stipulated that, child should receive only mOPV2 and resheduled for bOPV next contact. i have little imformation that needs clarification from immunzation experts and/or refference materials for capacity building in support of the guideline. 1. What is the possible consequence of given mOPV2 and bOPV at same time? any scientific justification. 2. Weighing the risk of missed oppurtunities and combining both antigens at same, which one should i prioritised? Thanks alot waiting for your input.

HLN Releases Update to its Award Winning Open Source Immunization Forecaster

On May 31, 2019, HLN released a new version (v1.17.1) of the Immunization Calculation Engine (ICE). ICE is a state-of-the-art open-source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR) and Personal Health Record (PHR) Systems. This version includes: Improvements to handling of duplicate shots. Duplicate shots typically represent "bad data" that has been passed into the ICE service. For two or more duplicate shots on the same day, ICE will select the vaccine that makes the most sense for the circumstance. See Two Shots, Same Vaccine Group, Same Day Exception Rules for the specifics on how this is handled for each vaccine group. Logic updates to DTP, HPV, and Zoster vaccine groups. See Release Notes for details. Pneumococcal interval fix in the Adult Series where (under certain circumstances) the PPSV to PPSV 5 year recommended interval is not being applied when there is a valid PCV shot in between the PPSV shots. The full software release is available for download at https://cdsframework.atlassian.net/wiki/display/ICE/Downloads. A revised ICE Implementation Guide is also available. See the feature article about ICE in Open Health News.

New WHA resolution on access to Medicines and Vaccines

Dear All, So pleased to share the great news that yesterday, the World Health Assembly adopted a resolution on improving the transparency of markets for medicines, vaccines and other health products in an effort to expand access. The draft resolution is on the WHA website: http://apps.who.int/gb/e/e_wha72.html#resolutions The resolution urges Member States to enhance public sharing of information on actual prices paid by governments and other buyers for health products, and greater transparency on pharmaceutical patents, clinical trial results and other determinants of pricing along the value chain from laboratory to patient. This is what WHO is working on with the Market Information for Access (MI4A) initiative - focusing on vaccines. https://www.who.int/immunization/programmes_systems/procurement/v3p/platform/en/  It was great to see the enthusiasm of countries such as Brazil, the African delegation with a strong statement from Botswana, but also Hungary, Mexico, India and many others. This resolution was led by Italy and cosponsored by 18 countries across all WHO regions. It is a great step forward in helping countries making informed decisions on vaccines and medicines procurement!

White paper on Harmonizing vaccination coverage measures available in English & French

A white paper is available on Technet-21. To access them in English or French – please see below links:  Harmonizing vaccination coverage measures in household surveys: A primer https://www.technet-21.org/en/?option=com_sobipro&sid=5300&pid=57&Itemid=2586  Guide pour l’harmonisation des indicateurs de couverture vaccinale dans le cadre des enquêtes auprès des ménages https://www.technet-21.org/en/?coption=com_sobipro&sid=5301&pid=57&Itemid=2586

A Bright Future—Helping to Power Primary Health Care with an Energy Harvest Control

In January 2019, PATH and the Solar Electric Light Fund (SELF) partnered with the government of Senegal to evaluate a smart energy management device attached to certain solar vaccine refrigerators that would enable health workers to use electric devices in areas with limited or unreliable power. Called an energy harvest control (EHC), the device consists of a smart switch that takes excess power generated from solar panels already powering the refrigerators and safely allows the energy to be used for devices such as lights, fans, mobile phones, and some medical devices. The EHC configuration varies by solar direct drive (SDD) refrigerator manufacturer, but each device can access the excess energy, including through USB ports or 12 VDC sockets. The evaluation is taking place in four health posts in the Meckhe and Tivaouane districts of Senegal. To date, three EHC devices have been prequalified by the World Health Organization (WHO) Performance, Quality and Safety (PQS) process—two SDD refrigerators with a built-in EHCa,b and one stand-alone systemc paired with a specific SDD refrigerator.d,e The need for better electrification One study found that of the 11 countries surveyed in sub-Saharan Africa, on average more than one-fourth lacked any access to electricity and close to three-fourths lacked access to a reliable supply of electricity.1 Electrification is a health equity issue—87 percent of those without electricity live in rural areas.2 Studies in Uganda demonstrated that access to midwives and electricity at health facilities had great impact, reducing the maternal fatality rate during emergency obstetric care by as much as 80 percent.3,4 Our goals for the EHC evaluation The evaluation in Senegal will assess whether these EHC devices: Perform according to the WHO PQS specifications in a real-use setting. Are acceptable and useful to end users. Have any unanticipated positive or negative effects on the health system. Better health care through energy harvest control This evaluation is a step forward in revolutionizing primary health care at the lowest levels of health systems. With the power provided by the EHC, health systems have improved options for: Communication. The ability to charge cell phones, remote temperature monitoring devices, and other small communication devices supports facilities to keep in touch with patients, share data with higher-level facilities, and order supplies. Management of health emergencies. Devices such as lights (for emergencies or births that happen at night)5 and neonatal ultrasound Dopplers for emergency obstetric care are prime examples of how EHC can enable better health care in hard-to-reach areas. Access to health care. By decreasing the amount of time health workers spend away from health facilities charging their devices, health staff can be more available for patient care. Quality of service: Patients must have a high degree of trust in their health centers to rely on them for their health needs, and that trust is either validated by receiving the proper care or broken through negative health interactions associated with a lack of basic equipment. Something as simple as basic lighting can help foster patient trust and improve perceptions regarding the reliability of their health system—and increase the likelihood that patients will seek help when needed. Preliminary feedback from health workers Users have had a positive response to the electricity provided through the EHC. A head nurse noted, “Now they [health workers] get light at night when women are giving birth or when they have urgency—instead of using candles, light from mobile phones, or flashlight lamps.” Users generally appreciated the extra power, used some of the study-provided loads, and charged additional loads like mobile phones and radios. The community had more positive perceptions regarding the health services provided by facilities as a result of the EHC devices. “From the EHC project,” noted one head nurse, “we now have medical material to better diagnose our patients, especially pregnant women (fetal Doppler, otoscope).” Next steps We expect to have results from the evaluation in June 2019, and funding has been identified to expand this study to evaluate more EHC devices preparing for PQS pre-qualification. Future work could include market-shaping activities, expanded implementation, and testing and evaluation of equipment that can be used with an EHC. Acknowledgement PATH acknowledges and appreciates the leadership shown by Steve McCarney in bringing EHC technology to market and his long-time role as champion of solar power for use in low-resource health care facilities. Contact Steven Diesburg, sdiesburg@path.org   Footnotes a. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=9e49ae2f-111c-45fb-a740-3ef325e9e1cd&TipoDoc=DataSheet&ID=0. b. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=c407d376-4d5e-4f43-a4aa-32f97676dd90&TipoDoc=DataSheet&ID=0. c. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=ab8a4a27-c68d-4362-8b1b-82bfe9aa573d&TipoDoc=DataSheet&ID=0. d. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=ef393d19-a915-4937-a10c-0502af93e177&TipoDoc=DataSheet&ID=0. e. See http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/LinkPDF.aspx?UniqueID=02f33f80-ec4a-4e23-9d53-bd9bbed31baa&TipoDoc=DataSheet&ID=0.   References 1. Adair-Rohani H, Zukor K, Bonjour S, et al. Limited electricity access in health facilities of sub-Saharan Africa: a systematic review of data on electricity access, sources, and reliability. Global Health, Science and Practice. 2013;1(2):249–261. https://doi.org/10.9745/GHSP-D-13-00037. 2. United Nations Department of Economic and Social Affairs (UNDESA). Analysis of the Voluntary National Reviews Relating to Sustainable Development Goal 7 - 2018. Geneva: UNDESA; 2018. https://sustainabledevelopment.un.org/content/documents/21159DESASDG7_VNR_Analysis2018_final.pdf. 3. Mbonye AK, Mutabazi MG, Asimwe JB, et al. Declining maternal mortality ratio in Uganda: priority interventions to achieve the Millennium Development Goal. International Journal of Gynaecology and Obstetrics. 2007;98(3):285–290. https://doi.org/10.1016/j.ijgo.2007.05.019. 4. Mbonye AK, Asimwe JB. Factors associated with skilled attendance at delivery in Uganda: results from a national health facility survey. International Journal of Adolescent Medicine and Health. 2010;22(2):249–155. 5. Suhlrie L, Bartram J, Burns J, Joca L, Tomaro J, Rehfuess E. The role of energy in health facilities: A conceptual framework and complementary data assessment in Malawi. PLoS One. 2018;13(7):e0200261. https://doi.org/10.1371/journal.pone.0200261.

Immunization Agenda 2030

As we approach the end of the Decade of Vaccines and with just a couple of years remaining on the Global Vaccine Action Plan (GVAP 2011-2020), a new Immunization Agenda 2030 is needed for the entire health and development community – one that re-affirms the benefits of vaccines and immunizations for a healthier, more secure and prosperous world through their contributions to the achievements of Universal Health Coverage (UHC) and Sustainable Development (SDG). An initial attempt to assemble ideas, thoughts and content for an Immunization Agenda 2030 is now available for broad review. It is being shared as a ‘draft zero’ and is offered as a starting point for further co-creation and co-development with immunization specialists, broader health experts, and wider health stakeholders at country, regional and global levels. We welcome your reactions and views on this document by 14 June 2019 either by:  • Providing quick feedback via an online survey: https://www.surveymonkey.com/r/IA2030 • Sending written comments to: immunizationagenda2030@who.int or • Posting comments online directly on the document at: https://drive.google.com/file/d/1Ct0Q1X7ZZch17EWdB5tnVM_qae17hTIx/view?usp=sharing - To do so, please select a word/sentence/paragraph, then click on the "+" on the right hand side of the page.  This document will continually evolve over the coming months based on you feedback. In addition, several dedicated regional consultations will be organized to ensure the voices of regional and country stakeholders are heard and that a bottom up process in co-developing the Immunization Agenda 2030 is implemented. For any queries, please send an email to: immunizationagenda2030@who.int 

Meeting of the Pan-African Parliamentarians (PAP) and AFRO

We must do more to make sure everyone has access to essential health services. Investing in #immunization can help strengthen health systems and advance #UHC. #ProtectedTogether #VaccinesWork I’m sharing the good news from this week’s meeting of the Pan-African Parliamentarians (PAP) and AFRO to advance the dialogue and commitments on the implementation of the African Union AU Declaration on Universal Access to Immunization. http://www.panafricanparliament.org/index.php/news-and-events/47-global-health-coverage-immunization-and-albinism-take-priority-at-pap-session This is (almost to the day) a year after launching the Immunization Business Case for the African Continent at the World Health Assembly (WHA71) by the DG (Dr Tedros) and AFRO RD (Dr Moeti). This is another big milestone as Parliamentarians will have a critical role to play in holding our Member States accountable for immunization outcomes. Getting their commitment is key to implementing the Addis Declaration on Immunization and the broader Immunization Agenda 2030!

New Topic page: EPI Core Reference Materials!

Announcing a new Topic resource page: EPI Core Reference Materials, now available on TechNet here: https://www.technet-21.org/en/topics/epi-core-reference
On this page, you will have accesss to a list of key reference materials published by the WHO Expanded Programme on Immunization (EPI), organized by antigen, themes, and groups. This page will continue to be updated as new global resources become available, so check back regularly!  Remember you can also find all documents, as well as additional immunization materials, in the Immunization, Vaccines and Biologicals (IVB) Document Centre on the WHO web.  

True Story of Elite Babies

Dear viewers  Several workshops were routinely held in the past and many more will be held in the future also especially to address urban immunization issues. Mission Director of Karnataka, in his inaugural speech expressed his deep apprehension as to whether the workshop will end with feasible solution. Some issues are perpetual look too complicated but very simple solutions are available which can be implemented with adrenaline speed in a sustainable way provided “bottom up approach, local tested innovations” are valued as iterated by GVAP as their 5th and 6th strategic objectives. Attached example represents lakhs of babies of elite family for whom right vaccines with known potency are either delayed or denied or administered with no known potency, vaccination data are not transferable to HMIS hence do not add to the countries progress. These children are deprived of the luxury of FIC before first birth day and complete immunization before 2nd birth day – 2 of the 4 critical key indicators of Intensified Mission Indradhanush – the most ambitious flagship programme of the country. But this is a “SOLVABLE PROBLEM”. Holla n Team

Simple VPD (e.g. measles or diphtheria) susceptibility analysis tool

Does anyone know or use a simplified susceptibility analysis tool that can be used at sub-national level? Is there a model of a simple susceptibility analysis tool likely to be used by people who are neither very much techno savvy nor have strong epidemiological background but need some guidance/ evidence to convince decision-makers to invest in the conduct of preventive vaccinations/outreach/ defaulter tracking by showing how many children are susceptible and there's an imminent outbreak? This will be linked to a request for local government funding and other basic support to carry out the necessary intervention way before an outbreak actually occurs. Something that is flexible (e.g. can be used for measles and/or diphtheria) and uses locally available or limited data. Any input is highly appreciated and thanks in advance.

IVIR-AC endorsement of WHO Market Information for Access Initiative and methodology

Hello, please check out recent feedback from the Immunization and vaccines related implementation research advisory committee (IVIR-AC) on the newly-launched WHO Market Information for Access Initiative (MI4A) and methodology: "The initiative is providing a valuable public good that could shape markets and ultimately save lives if greater transparency and less information asymmetry generally lead to more efficient markets." View the full IVIR-AC recommendations in the current edition of WHO's Weekly Epidemiological Record: https://apps.who.int/iris/bitstream/handle/10665/312312/WER9419.pdf MI4A provides a unique global perspective on vaccine markets, covering all countries and vaccines with objectives to: Enhance the understanding of global vaccine demand, supply and pricing dynamics and identifying affordability and shortage risks; Convene all relevant global health partners to contribute to the development of policies, strategies, and guidance to address the identified risks; Strengthen national and regional capacity for improved access to vaccines supply. For more information on MI4A please see: www.who.int/immunization/MI4A Tania

Temperature monitoring/recording

There are different types of cold chain monitoring devices such as freeze alert, Log tag, 30 DTR, and liquid thermometers. Among these devices, which device are more appropriate and convenient to use for monitoring temperature in refrigerators?

WHO releases a new Vaccine Wastage Calculator

Hello! We are happy to announce the release of the WHO Vaccine Wastage Rates Calculator. It can be downloaded from the WHO website at the following link: https://www.who.int/immunization/programmes_systems/supply_chain/resources/tools/en/ It is the culmination of many years of efforts to provide a rational guidance on vaccine wastage estimation.  As you know, wastage is an important parameter for vaccine forecasting needs and remain a sensitive indicator for vaccine utilization.  Therefore, wastage could impact both the immunization programme cost, coverage and equity. In 2002, WHO issued global indicative vaccine wastage rates to be used by countries in absence of national data. Nevertheless, they remain generic with significant limitations since they were not necessarily reflecting each specific vaccine service delivery setting. The new WHO Vaccine Wastage Rates Calculator was developed in response to these limitations. The development was supported by a WHO model based on binomial statistics, endorsed by the WHO’s Immunization Practices Advisory Committee (IPAC). The calculator will provide more precise vaccine wastage rates to support: EPI managers at country level, to provide accurate annual vaccine forecast, reducing stock out and over stocks; to adapt vaccine product presentation to country context; to reduce missed opportunities; finally, to improve coverage and equity; Partners at the global level, to improve predictable global demand and avoid global shortages. We would like to thank all individuals and partners who contributed greatly to the development of this new WHO Vaccine Wastage Rates Calculator. We welcome any suggestions and feedback from users that can help to further improve it! Best, Tania Cernuschi Group Manager - Supply, Technologies, and Financing  Expanded Programme on Immunization (EPI) | Dept of Immunization, Vaccines and Biologicals (IVB)  World Health Organization (WHO)
Admin

Submit successful stories about immunization programs

The Bill & Melinda Gates Foundation has partnered with Dalberg Design, a human-centered design firm focused on social impact, to surface and share “bright spots” in routine immunization—stories about immunization programs that have successfully improved performance at a subnational level in LICs and LMICs. They are interested in understanding these success stories to inform policy and decision-making, and to inspire actions to improve program performance. For additional details on this project, please see the one-page summary or FAQs (English or French). Please help us identify bright spots!  We hope you will consider taking a few minutes to share bright spot stories using their online form here. (The form is also available in French.) 

Looking for interviewees for my Master Thesis

Hey everybody! First of all, thanks for accepting me into this great community. I am currently enrolled in a Masters programme organised by the Barcelona Institute for Global Health (ISGlobal) and I was hoping to find some help for my Master thesis on here. Some context: For my thesis I have analysed changes in vaccine coverage in countries after they have transitioned from Gavi support. As some of you may know, as part of Gavis "Transition Policy", once countries reach a threshold of 1580 US$ GNI per capita, they are expected to gradually adopt more financing responsibilities, until they no longer receive any support after 5 years. For the next part of my thesis I have picked countries whose vaccine coverage either increased or decreased after being fully self-financing and am now looking for aspects that could explain these changes. The countries in question are: Armenia, Angola, DRC, Georgia and Moldava. A potential Interviewee would ideally have worked in the area of vaccine delivery or surveillance within the last 2-3 years. The interviews would be fairly short, I expect them to be somewhere between 10 and 15 minutes. If anyone would be willing and able to help, I would be eternally thankful! Thanks in advance. Cheers Lukas

NEW MCSP Blog Post- Tanzania Deploys the Most Advanced Health Information Exchange in sub-Saharan Africa

Across Tanzania, health providers often face the same problem: a lack of access to the data they need to make informed decisions and deliver high-quality care. Since the 2013 launch of the country’s National eHealth Strategy, the national government has made an earnest commitment to reverse this trend. USAID's Flagship Maternal & Child Survival Program supported the Ministry of Health, Community, Development, Gender, Elderly, and Children (MoHCDGEC) to lauch the Tanzania National Health Information Exchange (TzHIE), ensuring that information and data needed for policy development and the delivery of health care is readily available and used.  Please check out the link attached to find out more about MCSP's support in launching the TzHIE!    

A Common "COLD" Dilemma

Dear all Context: A visiting officer was discussing about as to how to practically keep vaccines in the cold-chain equipment at service points / planning units. Visiting officer was also discussing as to why the domestic refrigerator is not recommended by the CDC even for keeping vaccines as alternate equipment. On completing the discussion, thought of presenting the same in the coming Academic Society Meeting for the benefit of staff nurse, medical students, interns, post graduates who may have to provide vaccination services in their profession. Hence, we made this PPT using the photos taken at different planning units in different districts and states at different times for illustration. This is the draft PPT for presenting on 24-04-2019. Happy viewing Holla n Team

Refrigerator Problem in maintaining Cold Chain - GVR 50 DC SDD

Bula from the Fiji Islands
Im situated in an island here in Fiji and have a problem with my GVR 50 DC solar direct drive refrigerator The refrigerator is working, compressor light is on but the problem is the generator is powerless maintaining the cold in the refrigerator. Hope you would help me identify the problem and fix it...
With thanks
Admin

New Cold Chain Equipment area on TechNet

We are pleased to announce the launch of our Cold Chain Equipment (CCE) area. Are you: A current or future WHO PQS-prequalified product user who needs information to use or maintain a specific PQS device? A trainer in need of specific documents for training purpose? Looking for specific information to decide which products are more suitable to your needs? If yes, then the CCE area has everything you need to know. This includes installation and maintenance guides, training resources, brochures, related policy and recommendation documents, videos, photos, as well as product feedback from TechNet members. In addition, the community can participate to help each other. The CCE area is a crowdsourced space. Any user can share feedback on products (for example provide his/her experience on products (s)he uses, share pictures of the products, etc.), pictures, videos, resources (manuals, training resources, etc.) whether from official sources or self-made. This is a space built by the community for the community. PQS manufacturers can also manage their product pages and upload new documents to help the community to better understand and use their products. The CCE area is organised by PQS category and each PQS product has its own product page. This page provides a list of resources, technical details, videos, and user feedback. Browse the categories to find a product or use the internal search engine. If you have any question or comment, please post a reply below or get in touch with moderator@technet-21.org.

World Immunization Week

WORLD IMMUNIZATION WEEK VACCINES WORK VVM is one of the greatest inventions in public health. It is the only tool among all time-temperature indicators that is available at any time in the process of distribution and at the time a vaccine is administered. VVM indicates whether the vaccine has been exposed to a combination of excessive temperature over time and whether it is likely to have been damaged. https://www.slideshare.net/Umit/vaccines-work #vaccineswork #protectedtogether #worldimmunizationweek #VVM #vaccinevialmonitor #temptimecorporation

REQUEST FOR NOMINATION-05 days International training program on “Procurement and Supply Chain Management of Essential Medicines & In Vitro Diagnostics” from 26-30 August, 2019 at the IIHMR University Jaipur, India

Dear Sir/Madam Wish to share that under the aegis of  IIHMR University, Jaipur, 05 days International training program on “Procurement and Supply Chain Management of Essential Medicines & In Vitro Diagnostics”  is scheduled from 26-30 August, 2019 at the IIHMR University Jaipur, India The objective of the training program is to provide technical guidance for establishing a robust procurement and supply chain framework for ensuring supply of good quality essential medicines and diagnostics Program Contents : - Managing selection of essential medicines and diagnostics  Selection criteria’s Significance of EML, EDL, STD and Formularies Quantification and Forecasting Methods of quantification  Procurement of essential medicines and diagnostics Strategic objectives of good pharmaceutical procurement How to formulate tender specifications Tender evaluation Selecting correct procurement type Selection of appropriate supplier Procurement laws and regulations Pooled procurement mechanism  Warehousing, Storage and Distribution Guidelines for good storage practices Receiving and arranging commodities Monitoring and evaluation of drug distribution system  Quality Assurance and Donation of medicines WHO Prequalification of Medicines Program (WHO PQP) Quality inspections-Sampling and survey process    Combating Not of standard drugs/spurious drugs National guidelines on donation of medicines Max-Min Inventory control Types of Inventory control systems  Logistic Management Information System (LMIS) Types of Logistics records and their significance Rational use of drugs Role of drugs and therapeutics committee Diagnosis, prescribing, dispensing and patient adherence Pricing and sustainable financing Donor funding and pricing mechanism Monitoring and evaluation of supply chain Indicators for M&E of supply chains Policy and legal framework for procurement and supply chain National medicines policy Hands on training on Noninvasive techniques and rapid detection techniques for determining drug quality (Raman handheld spectroscopy) Field visit to drug warehouse    PROGRAMME FEE         For Indian participants                : Rs 37,500 per participant plus 18% GST For Foreign participants             : USD 700 per participant plus 18% GST The fees cover tuition fees, training material, stay in air-conditioning room (twin-sharing basis), breakfast, lunch, dinner, tea/coffee during the program and pick-up and drop from Jaipur airport/railway station/bus stand. Welcome dinner and short-trip to historical and cultural importance places in Jaipur would be offered by the University in honor of the participants. Participants would be encouraged to use library facilities. Around the clock internet facility (Wi-Fi) is available for the participants. The travel tickets from the country of origin to Jaipur and vice versa are to be borne by the participant/sponsoring agency. DISCOUNTS ON THE FEE Early Bird Discount: Nominations received with payments on/before 4-weeks (29th July 2019) will be entitled to an early bird discount of 10%. Group Discount: Any organization sponsoring four or more participants to the program will be entitled for a discount of 20% on the total fee payable provided that at least four participants attend the program. Maximum Discount: Organization can avail themselves of both the discount subject to maximum discount of 20%. I am sure that you will find it useful for the organization/national health system program. I would be grateful, if you could participate/nominate interested candidates in the training program. You may forward to concerned department also Kindly send the interest to the program coordinator at saurabh@iihmr.edu.in   Looking forward for your kind cooperation and support to make the program success. A word of response would be appreciated. Regards   Dr.Saurabh kumar Banerjee  M.Pharm, Ph.D., MBA Associate  Professor and Program Coordinator The IIHMR University, 1 Prabhu Dayal Marg, Near Sanganer Airport Jaipur (Pin-302029), Rajasthan, INDIA Office: +91 141 3924700, Ext: 789,  Mobile +91-8890398067 Email: saurabh@iihmr.edu.in

Vaccine Carrier Product Research

Hi everyone, if you have ever used a vaccine cooler or similar device, I would greatly appreciate your input in this survey. It should take about 3 minutes to complete.
Thanks in advance https://www.surveymonkey.com/r/KKNHHLG

SEEKING VACCINE DELIVERY EXPERTS: Invitation to complete a survey on IMMUNIZATION OUTREACH

WHO/HQ/EPI is interested in strengthening immunization outreach efforts by creating some related job aids for health workers.  To this end, we would appreciate your perspective on some of the barriers undermining this critical part of vaccination activities.  We request you to complete a small 5 to 10 minutes survey.    Should you know of additional experts with first-hand knowledge and experience around this issue, please forward this survey to them.  The survey will be open for participation until Monday, February 5th, though the sooner we receive enough responses, the better.  Please be aware that the survey remains fully confidential and the results will not be published, nor shared with anyone outside of the WHO-HQ EPI team. Thank you very much for your contribution!    https://www.surveymonkey.com/r/2Y6R72P


There are no discussions available here currently
  1. Posts: 2764
  2. Latest Member: Yusuf Muse Awale
Online Members